1. Contractors
  2. Spaulding Clinical Research, LLC

Spaulding Clinical Research, LLC

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Spaulding Clinical Research has 2 federal contracts of $100,000 or more active since October 2023, with $11.5M obligated, from 1 agency. None is running now.

Contracts
2 since FY2024$11,454,392 obligated, contracts of $100,000 or more
Running now
None2 ended in the last 12 months
Biggest customer
Food and Drug Administration$11.5M on 2 contracts
UEI
HERBKHMPKQN5Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$5,454,072
FY2023$6,000,321

Running contracts

No contract of $100,000 or more is running now.

Who they work for

AgencyAmount
Food and Drug Administration2 contracts$11,454,392

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts$11,454,392

Where the work is

Place of workAmount
Wisconsin1 contract$6,000,321
Maryland1 contract$5,454,072

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.

Get new notices like Spaulding Clinical Research's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy